Brian D Bradbury
Overview
Explore the profile of Brian D Bradbury including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1759
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Riskin D, Monda K, Gagne J, Reynolds R, Garan A, Dreyer N, et al.
JAMA Netw Open
. 2025 Mar;
8(3):e250128.
PMID: 40063029
Importance: While it is well known that data quality underlies evidence validity, the measurement and impacts of data reliability are less well understood. The need has been highlighted in the...
2.
Hernandez R, Critchlow C, Dreyer N, Lash T, Reynolds R, Sorensen H, et al.
Clin Pharmacol Ther
. 2025 Jan;
PMID: 39807817
A compilation of factors over the past decade-including the availability of increasingly large and rich healthcare datasets, advanced technologies to extract unstructured information from health records and digital sources, advancement...
3.
Barberio J, Naimi A, Patzer R, Kim C, Hernandez R, Brookhart M, et al.
Am J Epidemiol
. 2025 Jan;
PMID: 39756369
No abstract available.
4.
Curtis J, Arora T, Liu Y, Lin T, Spangler L, Brunetti V, et al.
J Bone Miner Res
. 2024 May;
39(7):826-834.
PMID: 38753892
Although clinical trials have shown that denosumab significantly increases bone mineral density at key skeletal sites more than oral bisphosphonates, evidence is lacking from head-to-head randomized trials evaluating fracture outcomes....
5.
Barberio J, Naimi A, Patzer R, Kim C, Hernandez R, Brookhart M, et al.
Am J Epidemiol
. 2024 Apr;
193(9):1281-1290.
PMID: 38583932
Administrative claims databases often do not capture date or fact of death, so studies using these data may inappropriately treat death as a censoring event-equivalent to other withdrawal reasons-rather than...
6.
Muntner P, Hernandez R, Kent S, Browning J, Gilbertson D, Hurwitz K, et al.
Pharmacoepidemiol Drug Saf
. 2024 Feb;
33(3):e5770.
PMID: 38419140
Purpose: We describe constructs designed to protect the integrity of the results from comparative analyses using real-world data (RWD): staging and clean room. Methods: Staging involves performing sequential preliminary analyses...
7.
Sing C, Lin T, Bartholomew S, Bell J, Bennett C, Beyene K, et al.
J Bone Miner Res
. 2023 Apr;
38(8):1064-1075.
PMID: 37118993
In this international study, we examined the incidence of hip fractures, postfracture treatment, and all-cause mortality following hip fractures, based on demographics, geography, and calendar year. We used patient-level healthcare...
8.
Kim M, Lin T, Arora T, Zhao H, Balasubramanian A, Stad R, et al.
J Bone Miner Res
. 2023 Apr;
38(6):829-840.
PMID: 37088886
It is often difficult to obtain valid estimates of comparative treatment effectiveness and safety owing to differences across patient populations taking different medications in the real world. One approach for...
9.
Levintow S, Nielson C, Hernandez R, Breskin A, Pritchard D, Lash T, et al.
Pharmacoepidemiol Drug Saf
. 2023 Mar;
32(6):599-606.
PMID: 36965103
Purpose: This narrative review describes the application of negative control outcome (NCO) methods to assess potential bias due to unmeasured or mismeasured confounders in non-randomized comparisons of drug effectiveness and...
10.
Hernandez R, Nakasian S, Bollinger L, Bradbury B, Jick S, Muntner P, et al.
Ther Innov Regul Sci
. 2022 Dec;
57(3):570-579.
PMID: 36562933
Purpose: Evaluation of drug safety during pregnancy is dependent on the number of exposed women during routine clinical practice with data available for analysis. We examined medication fills in pregnant...